Abstract
Abstract. Meningococcal meningitis, caused by Neisseria meningitidis, is a serious bacterial infection characterized by inflammation of the membranes surrounding the brain. Meningococcal vaccines currently in use fail to protect against N. meningitidis strains belonging to serogroup B. A new vaccine, Bexsero®, has recently been developed by Novartis for use against serogroup B meningococci. This vaccine contains five different protein components: fHbp, NHBA, NadA, GNA1030 and GNA2091. Although the vaccine has been designed to elicit the production of antibodies that kill N. meningitidis, it is possible the antibodies could also affect other beneficial bacteria living in or on the human body that express similar surface antigens. The goal of the current study was to assess this possibility by using bioinformatics approaches to search for the five vaccine antigen-encoding genes in all microorganisms represented in the Human Microbiome Project reference genome database. The fHbp gene was found in N. cinerea ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.